Moolec Science (MLEC) Competitors $0.86 -0.02 (-2.29%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends MLEC vs. MNTN, PHYT, GATE, ACR, ESHA, APPS, RCFA, PLAO, TCOA, and APXIShould you be buying Moolec Science stock or one of its competitors? The main competitors of Moolec Science include Everest Consolidator Acquisition (MNTN), Pyrophyte Acquisition (PHYT), Marblegate Acquisition (GATE), ACRES Commercial Realty (ACR), ESH Acquisition (ESHA), Digital Turbine (APPS), RCF Acquisition (RCFA), Patria Latin American Opportunity Acquisition (PLAO), Zalatoris Acquisition (TCOA), and APx Acquisition Corp. I (APXI). These companies are all part of the "trading" industry. Moolec Science vs. Everest Consolidator Acquisition Pyrophyte Acquisition Marblegate Acquisition ACRES Commercial Realty ESH Acquisition Digital Turbine RCF Acquisition Patria Latin American Opportunity Acquisition Zalatoris Acquisition APx Acquisition Corp. I Moolec Science (NASDAQ:MLEC) and Everest Consolidator Acquisition (NYSE:MNTN) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, community ranking, earnings, profitability, risk, media sentiment and valuation. Does the MarketBeat Community favor MLEC or MNTN? Moolec Science received 3 more outperform votes than Everest Consolidator Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformMoolec ScienceOutperform Votes3100.00% Underperform VotesNo VotesEverest Consolidator AcquisitionN/AN/A Which has more risk & volatility, MLEC or MNTN? Moolec Science has a beta of -0.54, suggesting that its share price is 154% less volatile than the S&P 500. Comparatively, Everest Consolidator Acquisition has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Which has preferable earnings and valuation, MLEC or MNTN? Everest Consolidator Acquisition has lower revenue, but higher earnings than Moolec Science. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMoolec Science$5.62M5.85-$7.31M-$0.20-4.28Everest Consolidator AcquisitionN/AN/AN/AN/AN/A Do analysts recommend MLEC or MNTN? Moolec Science currently has a consensus price target of $6.00, indicating a potential upside of 601.75%. Given Moolec Science's stronger consensus rating and higher probable upside, equities research analysts plainly believe Moolec Science is more favorable than Everest Consolidator Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moolec Science 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Everest Consolidator Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of MLEC or MNTN? 0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 72.9% of Everest Consolidator Acquisition shares are owned by institutional investors. 19.9% of Moolec Science shares are owned by company insiders. Comparatively, 36.8% of Everest Consolidator Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is MLEC or MNTN more profitable? Everest Consolidator Acquisition has a net margin of 0.00% compared to Moolec Science's net margin of -129.97%. Everest Consolidator Acquisition's return on equity of 0.00% beat Moolec Science's return on equity.Company Net Margins Return on Equity Return on Assets Moolec Science-129.97% -97.95% -27.91% Everest Consolidator Acquisition N/A N/A N/A Does the media prefer MLEC or MNTN? In the previous week, Moolec Science had 1 more articles in the media than Everest Consolidator Acquisition. MarketBeat recorded 1 mentions for Moolec Science and 0 mentions for Everest Consolidator Acquisition. Everest Consolidator Acquisition's average media sentiment score of 1.03 beat Moolec Science's score of 0.00 indicating that Everest Consolidator Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Moolec Science Neutral Everest Consolidator Acquisition Positive SummaryEverest Consolidator Acquisition beats Moolec Science on 7 of the 13 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Moolec Science News Delivered to You Automatically Sign up to receive the latest news and ratings for MLEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLEC vs. The Competition Export to ExcelMetricMoolec ScienceHolding Offices IndustryStaples SectorNASDAQ ExchangeMarket Cap$32.87M$257.56M$14.91B$8.81BDividend YieldN/A7.63%2.68%4.06%P/E Ratio-4.289.0823.9717.77Price / Sales5.84119.823.6575.18Price / CashN/A84.5619.1432.53Price / Book4.7591.265.894.68Net Income-$7.31M$32.24M$581.83M$226.08M7 Day Performance3.01%-0.21%0.02%-1.04%1 Month Performance-1.59%-4.81%-3.10%1.04%1 Year Performance-66.21%14.31%9.98%26.28% Moolec Science Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLECMoolec Science1.1809 of 5 stars$0.86-2.3%$6.00+601.8%-65.8%$33.44M$5.62M-4.284MNTNEverest Consolidator AcquisitionN/A$11.41+0.3%N/A+5.1%$133.14MN/A0.002Positive NewsPHYTPyrophyte AcquisitionN/A$11.55flatN/A+5.5%$130.75MN/A0.002GATEMarblegate AcquisitionN/A$11.19flatN/AN/A$129.60MN/A0.003ACRACRES Commercial Realty3.2401 of 5 stars$16.72+0.4%$17.50+4.7%+116.5%$128.74M$91.13M19.902,018ESHAESH AcquisitionN/A$10.68-0.1%N/A+5.1%$125.90MN/A0.00N/AHigh Trading VolumeAPPSDigital Turbine4.1096 of 5 stars$1.43+18.2%$2.38+66.1%-73.0%$125.51M$544.48M0.00840Short Interest ↓Gap UpRCFARCF AcquisitionN/A$11.45-0.4%N/AN/A$120.57MN/A0.002,021PLAOPatria Latin American Opportunity AcquisitionN/A$11.63flatN/A+5.3%$119.69MN/A0.00N/ATCOAZalatoris AcquisitionN/A$11.07flatN/AN/A$118.12MN/A0.00N/AAPXIAPx Acquisition Corp. IN/A$11.87flatN/A+7.5%$117.63MN/A0.00N/APositive News Related Companies and Tools Related Companies MNTN Competitors PHYT Competitors GATE Competitors ACR Competitors ESHA Competitors APPS Competitors RCFA Competitors PLAO Competitors TCOA Competitors APXI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MLEC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moolec Science SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Moolec Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
